Although IL-6 has been regarded as a pro-inflammatory cytokine that is classically associated with endothelial dysfunction and atherosclerosis [36], we found no differences in secretome or circulating levels between the group of patients suffering from atherosclerosis and the mammary artery. Here, IL6 is linked to atherosclerosis.